151 related articles for article (PubMed ID: 15520527)
21. Diffuse-disseminated sclerosis combined with partial arylsulfatase A (ASA) deficiency. Mixed heterozygosity of ASA- and pseudo-ASA-deficiency?
Peiffer J; Harzer K; Schlote W
Neuropediatrics; 1984 May; 15(2):59-62. PubMed ID: 6146104
[TBL] [Abstract][Full Text] [Related]
22. Intracellular sulfatide expression in a subpopulation of astrocytes in primary cultures.
Berntson Z; Hansson E; Rönnbäck L; Fredman P
J Neurosci Res; 1998 Jun; 52(5):559-68. PubMed ID: 9632312
[TBL] [Abstract][Full Text] [Related]
23. Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology.
Hohenschutz C; Friedl W; Schlör KH; Waheed A; Conzelmann E; Sandhoff K; Propping P
Am J Med Genet; 1988 Sep; 31(1):169-75. PubMed ID: 2906225
[TBL] [Abstract][Full Text] [Related]
24. Distribution of C16:0, C18:0, C24:1, and C24:0 sulfatides in central nervous system lipid rafts by quantitative ultra-high-pressure liquid chromatography tandem mass spectrometry.
Moyano AL; Li G; Lopez-Rosas A; Månsson JE; van Breemen RB; Givogri MI
Anal Biochem; 2014 Dec; 467():31-9. PubMed ID: 25205652
[TBL] [Abstract][Full Text] [Related]
25. Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy.
Stroobants S; Leroy T; Eckhardt M; Aerts JM; Berckmans D; D'Hooge R
Behav Brain Res; 2008 Jun; 189(2):306-16. PubMed ID: 18336930
[TBL] [Abstract][Full Text] [Related]
26. Imaging of complex sulfatides SM3 and SB1a in mouse kidney using MALDI-TOF/TOF mass spectrometry.
Marsching C; Eckhardt M; Gröne HJ; Sandhoff R; Hopf C
Anal Bioanal Chem; 2011 Jul; 401(1):53-64. PubMed ID: 21359825
[TBL] [Abstract][Full Text] [Related]
27. Generation and characterization of the binding epitope of a novel monoclonal antibody to sulfatide (sulfogalactosylceramide) OL-2: applications of antigen immunodetections in brain tissues and urinary samples.
Colsch B; Baumann N; Ghandour MS
J Neuroimmunol; 2008 Jan; 193(1-2):52-8. PubMed ID: 18023883
[TBL] [Abstract][Full Text] [Related]
28. Olaparib Attenuates Demyelination and Neuroinflammation in an Organotypic Slice Culture Model of Metachromatic Leukodystrophy.
Mekhaeil M; Conroy MJ; Dev KK
Neurotherapeutics; 2023 Sep; 20(5):1347-1368. PubMed ID: 37525026
[TBL] [Abstract][Full Text] [Related]
29. The interaction of lead exposure and arylsulfatase A genotype affects sulfatide catabolism in human fibroblasts.
Poretz RD; Yang A; Deng W; Manowitz P
Neurotoxicology; 2000 Jun; 21(3):379-87. PubMed ID: 10894127
[TBL] [Abstract][Full Text] [Related]
30. Sulfatide storage in visceral organs of arylsulfatase A-deficient mice.
Schott I; Hartmann D; Gieselmann V; Lüllmann-Rauch R
Virchows Arch; 2001 Jul; 439(1):90-6. PubMed ID: 11499846
[TBL] [Abstract][Full Text] [Related]
31. Mannose 6-phosphate receptor-dependent endocytosis of lysosomal enzymes is increased in sulfatide-storing kidney cells.
Klein D; Yaghootfam A; Matzner U; Koch B; Braulke T; Gieselmann V
Biol Chem; 2009 Jan; 390(1):41-8. PubMed ID: 19007310
[TBL] [Abstract][Full Text] [Related]
32. Retrovirally expressed human arylsulfatase A corrects the metabolic defect of arylsulfatase A-deficient mouse cells.
Matzner U; Habetha M; Gieselmann V
Gene Ther; 2000 May; 7(9):805-12. PubMed ID: 10822308
[TBL] [Abstract][Full Text] [Related]
33. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
[TBL] [Abstract][Full Text] [Related]
34. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.
Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V
Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092
[TBL] [Abstract][Full Text] [Related]
35. Effect of glucose deprivation on sulfatide synthesis and oligodendrocytes in cultured brain cells of newborn mice.
Zuppinger K; Wiesmann U; Siegrist HP; Schäfer T; Sandru L; Schwarz HP; Herschkowitz N
Pediatr Res; 1981 Apr; 15(4 Pt 1):319-25. PubMed ID: 6111779
[No Abstract] [Full Text] [Related]
36. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
[TBL] [Abstract][Full Text] [Related]
37. Dysfunction of platelet-derived growth factor receptor α (PDGFRα) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells.
Pituch KC; Moyano AL; Lopez-Rosas A; Marottoli FM; Li G; Hu C; van Breemen R; Månsson JE; Givogri MI
J Biol Chem; 2015 Mar; 290(11):7040-53. PubMed ID: 25605750
[TBL] [Abstract][Full Text] [Related]
38. Galactosylceramide sulfotransferase, arylsulfatase A and cerebroside sulfatase activity in different regions of developing rat brain.
van der Pal RH; Klein W; van Golde LM; Lopes-Cardozo M
Biochim Biophys Acta; 1990 Mar; 1043(1):91-6. PubMed ID: 1968763
[TBL] [Abstract][Full Text] [Related]
39. Elevated sulfatide levels in neurons cause lethal audiogenic seizures in mice.
van Zyl R; Gieselmann V; Eckhardt M
J Neurochem; 2010 Jan; 112(1):282-95. PubMed ID: 19860853
[TBL] [Abstract][Full Text] [Related]
40. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
